You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

iCCA

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intrahepatic Cholangiocarcinoma Trial (derazantinib)

Available
  • Intrahepatic Cholangiocarcinoma
  • (no location specified)
Jan 13, 2023

Advanced Intrahepatic Cholangiocarcinoma Trial (Pemigatinib)

Not yet recruiting
  • Advanced Intrahepatic Cholangiocarcinoma
  • (no location specified)
Sep 30, 2022

Intrahepatic Cholangiocarcinoma Trial in Bad Saarow (Atezolizumab, Derazantinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Bad Saarow, Germany
    HELIOS KLinikum Bad Saarow
Jun 2, 2022

Early Identification of Candida in Intra-abdominal Candidiasis

Recruiting
  • Candida Sepsis
  • +3 more
  • calscreener
  • Vandoeuvre les Nancy, France
    Central Hospital
Feb 22, 2022

Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma, Determine Efficacy of Liver Transplantation After Neoadjuvant

Not yet recruiting
  • Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Liver Transplant
  • Newark, New Jersey
  • +1 more
Nov 14, 2023

Intrahepatic Cholangiocarcinoma Trial in Toronto (Deceased donor Liver Transplantation)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Deceased donor Liver Transplantation
  • Toronto, Ontario, Canada
    University Health Network
Apr 8, 2022

Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Common Bile Duct Tumors Trial in Rotterdam (Endoscopic Ultrasound

Recruiting
  • Hilar Cholangiocarcinoma
  • +4 more
  • Endoscopic Ultrasound registration
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus University Medical Center
Jan 11, 2023

Advanced Cholangiocarcinoma, FGFR2 Gene Rearrangements Trial in Worldwide (TAS-120, Cisplatin/Gemcitabine)

Active, not recruiting
  • Advanced Cholangiocarcinoma
  • FGFR2 Gene Rearrangements
  • Albuquerque, New Mexico
  • +100 more
Feb 1, 2023

Common Bile Duct Tumors, Non-Neoplastic Bile Duct Disorder Trial in Worldwide (AI model classification, DSOC endoscopist

Active, not recruiting
  • Common Bile Duct Neoplasms
  • Non-Neoplastic Bile Duct Disorder
  • AI model classification
  • DSOC endoscopist experts' classification
  • New Brunswick, New Jersey
  • +5 more
Mar 30, 2022

Advanced or Metastatic Solid Tumor, Advanced or Metastatic Gastric or Gastroesophageal Cancer, Myeloid or Lymphoid Tumors (MLN)

Active, not recruiting
  • Advanced or Metastatic Solid Tumor
  • +2 more
  • Gilbert, Arizona
  • +60 more
Oct 20, 2022

Intrahepatic Cholangiocarcinoma, Combined Hepatocellular and Cholangiocarcinoma Trial in Worldwide (derazantinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Combined Hepatocellular and Cholangiocarcinoma
  • Phoenix, Arizona
  • +40 more
Mar 7, 2022

Biliary Tract Cancer, Cholangiocarcinoma Trial in Italy (Gemcitabine, Nab paclitaxel, Cisplatin)

Not yet recruiting
  • Biliary Tract Cancer
  • Cholangiocarcinoma
  • Ancona, Italy
  • +18 more
Sep 16, 2023

Intrahepatic Cholangiocarcinoma Trial (procedure, drug, biological)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Biopsy
  • +7 more
  • (no location specified)
Sep 21, 2023

Perihilar Cholangiocarcinoma, Klatskin Tumor, Bile Duct Cancer Trial in Oslo (Liver transplant)

Recruiting
  • Perihilar Cholangiocarcinoma
  • +2 more
  • Liver transplant
  • Oslo, Norway
    Oslo university hospital
Aug 5, 2021

Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,

Not yet recruiting
  • Biliary Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
May 13, 2023

Intrahepatic Cholangiocarcinoma Trial in Germany (Durvalumab, Tremelimumab)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Dresden, Germany
  • +7 more
Apr 13, 2022

Biliary Tract Cancer, Candonilimab, Claudin 18.2 Trial in Shanghai (cardonilizumab, LM-302)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Shanghai, China
    Zhongshan hospital, Fudan University
Aug 12, 2023

Intrahepatic Cholangiocarcinoma Trial in Padova (Liver transplantation)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Liver transplantation
  • Padova, Italy
    Azienda Ospedale Università di Padova
Oct 25, 2023

Cholangiocarcinoma, Intrahepatic Trial in Toronto (Liver Transplantation)

Enrolling by invitation
  • Cholangiocarcinoma, Intrahepatic
  • Liver Transplantation
  • Toronto, Ontario, Canada
    University Health Network
Apr 8, 2022

Solid Tumor Trial in Italy, United States (Derazantinib low dose range, Derazantinib middle dose range, Derazantinib high dose

Completed
Has Results
  • Solid Tumor
  • Derazantinib low dose range
  • +3 more
  • Scottsdale, Arizona
  • +11 more
Mar 7, 2022

Intrahepatic Cholangiocarcinoma Trial in Fairfax (Induction Chemotherapy Triplet Therapy, Concurrent Y-90 treatment,

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Induction Chemotherapy Triplet Therapy
  • +2 more
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Jun 14, 2022

Intrahepatic Cholangiocarcinoma Trial (Famitinib)

Withdrawn
  • Intrahepatic Cholangiocarcinoma
  • (no location specified)
Jun 16, 2021

Septic Shock Trial in Rouen (Prolonged sedation with isoflurane, Prolonged sedation with midazolam)

Recruiting
  • Septic Shock
  • Prolonged sedation with isoflurane
  • Prolonged sedation with midazolam
  • Rouen, France
    Rouen University Hospital
Jan 12, 2021

Cholangiocarcinoma, Perihilar, Surgery Trial in Wuhan (Three dimensional laparoscopic resection for pCCA, Open resection for

Recruiting
  • Cholangiocarcinoma, Perihilar
  • Surgery
  • Three dimensional laparoscopic resection for pCCA
  • Open resection for pCCA
  • Wuhan, Hubei, China
  • +1 more
Oct 5, 2020

Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed

Completed
  • Intrahepatic Cholangiocarcinoma
  • +2 more
    • Atlanta, Georgia
    • +5 more
    Jun 7, 2017